Advertisement

Topics

Aurora Capital Group Company Profile

20:52 EDT 24th September 2017 | BioPortfolio


News Articles [1394 Associated News Articles listed on BioPortfolio]

Aurora Cannabis Inc. erwirbt den führenden Medizinalcannabis Anbieter Pedanios für 15,7 Mio. Euro - Think.Health realisiert zweiten erfolgreichen Exit in 6 Monaten

Berlin/Vancouver (ots) - Aurora Cannabis Inc. ("Aurora") (TSXV: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) und Think.Health Ventures ("Think.Health") geben bekannt, dass Aurora sämtliche Ges.....

Autism Learning Partners Expands to Aurora and the Greater Denver Metro Colorado Area & Continues to Serve as the Nation’s Leader in Autism Services

Aurora, Colorado (PRWEB) May 16, 2017 Autism Learning Partners (“ALP”), a national provider of therapy to children with au...

Babyscripts Lands $5.7M to Expand Virtual Prenatal Care Platform for Expecting Mothers

Babyscripts, a Washington, DC-based digital health startup has raised $5.7 million in funding led by Ysios Capital. The funding round also included participation from Chemo Group, CG Health Ventures, ...

GL Capital-led consortium to buy SciClone Pharmaceuticals

A consortium featuring entities affiliated with GL Capital Management GP, Bank of China Group Investment (BOCGI), CDH Investments, Ascendent Capital Partners and Boying will acquire all the outstandin...

Baird Capital backs Prescient Healthcare Group

Group invests in the consultancy by dipping into its $310m fund

Heavily armed men storm hotel and a casino resort in Philippine capital

Gunfire was reported at a hotel and a casino resort in the Philippine capital on Friday, the operator of the complex said, and the Islamic State group (IS) quickly claimed responsibility. “Resorts ...

Synlogic closes $42mm Series C financing

Synlogic Inc. raised $42mm through a Series C preferred stock financing to first-time backers Aju IB Investment, Ally Bridge Group, Arctic Aurora LifeScience, CLI Ventures, Perceptive Advisors, Rock S...

Series B round brings $55mm to Replimune

Replimune Group Inc. (oncolytic immunotherapies) raised $55mm through its Series B round. First-time investors Foresite Capital (lead and new board member), Bain Capital Life Sciences, Redmile Group, ...

PubMed Articles [2830 Associated PubMed Articles listed on BioPortfolio]

Aurora kinases: novel therapy targets in cancers.

Aurora kinases, a family of serine/threonine kinases, consisting of Aurora A (AURKA), Aurora B (AURKB) and Aurora C (AURKC), are essential kinases for cell division via regulating mitosis especially t...

Aurora kinase A interacts with H-Ras and potentiates Ras-MAPK signaling.

In cancer, upregulated Ras promotes cellular transformation and proliferation in part through activation of oncogenic Ras-MAPK signaling. While directly inhibiting Ras has proven challenging, new insi...

Aurora A Kinase Is a Priority Pharmaceutical Target for the Treatment of Cancers.

Aurora kinases control multiple events during cell cycle progression and are essential for mitotic and meiotic bipolar spindle assembly and function. There are three Aurora kinases in mammals, some of...

Characterization of Aurora A and Its Impact on the Effect of Cisplatin-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer.

Aurora A, as a member of serine/threonine kinase family and a common characteristic of epithelial cancers, plays a critical role in cell mitosis. However, the clinical significance of Aurora A in non-...

The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line.

Adrenocortical tumor (ACT) is a malignancy with a low incidence rate and the current therapy for advanced disease has a limited impact on overall patient survival. A previous study from our group sugg...

Clinical Trials [3178 Associated Clinical Trials listed on BioPortfolio]

A Two-Phase Clinical Study of the Minerva AURORA Ablation System

The primary objective of this study is to evaluate the use of the Aurora Ablation System in reducing menstrual blood loss at 12 months post-treatment. The occurrence of adverse events wil...

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

RATIONALE: Aurora A kinase inhibitor MLN8237 and bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I/II trial is s...

A VX-680 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Cancer

The purpose of this trial is to study an investigational drug in patients with recurrent or non-responsive solid tumors, or cancers for which standard therapy does not exist.

Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors

RATIONALE: Aurora B/C kinase inhibitor GSK1070916A (GSK1070916A) may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I trial is ...

Companies [2592 Associated Companies listed on BioPortfolio]

The Aurora Funds, Inc.

The Aurora Funds is a family of venture capital funds committed to providing resources to help early stage healthcare and information technology companies reach their full potential. Aurora’s invest...

Aurora Capital Group

Aurora Biofuels

Aurora Biofuels manufactures fuel from optimized algae in a patented production process. Leading technologists at Aurora Biofuels have engineered a cost-competitive and scalable method for fuel gene...

Aurora Algae

Aurora Algae is a producer of high-performance, premium algae-based products for the pharmaceutical, nutrition, aquaculture and fuels markets. The company has developed the indust...

Aurora Imaging Technology Inc.

Aurora Imaging Technology Inc. is a private company based in North Andover, Mass. committed to the fight against breast cancer. Aurora strives to manufacture the highest quality a...

More Information about "Aurora Capital Group" on BioPortfolio

We have published hundreds of Aurora Capital Group news stories on BioPortfolio along with dozens of Aurora Capital Group Clinical Trials and PubMed Articles about Aurora Capital Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aurora Capital Group Companies in our database. You can also find out about relevant Aurora Capital Group Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record